Condition: Colorectal Liver Metastases · Sponsor: Society of Interventional Oncology
To demonstrate that microwave ablation (MWA) of up to 3 hepatic metastases, each with a maximum diameter of ≤ 2.5 cm will result in a 2-year local progression free survival of at least 90%. This is a standard of care (SOC) study.
This description comes directly from the study's public registry record.
Research Manager · 202-367-1164 · ACCLAIM@SIO-central.org
Always discuss trial participation with your own doctor first.
| Miami Cancer Institute | Miami, Florida, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | Recruiting |
| MD Anderson Cancer Center | Houston, Texas, United States | Recruiting |
| Medical College of WI | Milwaukee, Wisconsin, United States | Recruiting |
| National and Kapodistrian University of Athens (NKUA) | Athens, Greece | Recruiting |
| Amsterdam UMC | Amsterdam, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05265169